Dear Shareholders,
We are now at the end of the third quarter of 2026 and a lot has happened since the last news update.
At the beginning of September, there was a major change in ownership in the company when Peptonic AB (public) (active in women’s health) acquired a stake in DGH corresponding to approximately 8.3% of the share capital.
EBM and the State Prosecutor Thomas Hertz, communicated, via articles in Affärsvärlden earlier this month that he is releasing the funds regarding the corporate fine, however, he maintains that it will amount to 100 MSEK as previously communicated.
Regarding the arbitration with Height Capital Management (HCM), it is proceeding according to plan and is expected to be completed in Q2/Q3 2027. Arbitration proceedings are confidential so the company cannot share information with shareholders or others.
We will hold a strategy meeting in mid-October with he board of directors of DGH and the management of Daro Group. The purpose of this meeting is to decide on the way forward for Daro Group in terms of business development, product development, financial goals and organization. We will return with a more in-depth presentation of Daro Group.
We have completed the half-year financial statements for each company, which are summarized below (comparative figures for DGH 2025 not relevant)(All amounts in KSEK)
Kind regards,
Fredrik Olsson
Chairman of the Board
DGH International AB / DARO Group UK